Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: Almost identical MLL breakpoints in therapy-related AML after treatment without etoposides

Genes Chromosomes and Cancer

Volumn 36, Issue 4, 2003, Pages 393-401

  Langer, Thorsten ^a   Metzler, Markus ^a   Reinhardt, Dirk ^b   Viehmann, Susanne ^c   Borkhardt, Arndt ^c   Reichel, Martin ^a   Stanulla, Martin ^d   Schrappe, Martin ^d   Creutzig, Ursula ^b   Ritter, Jörg ^b   Leis, Thomas ^a   Jacobs, Ulla ^a   Harbott, Jochen ^c   Beck, Jörn D ^a   Rascher, Wolfgang ^a   Repp, Reinald ^a,e  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e KLINIKUM FULDA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DNA FRAGMENT; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AF9 GENE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BONE MARROW EXAMINATION; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CENTROMERE; CHILD; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA SEQUENCE; FEMALE; GENE; GENE AMPLIFICATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFANT; INTRON; MALE; MLL GENE; NEWBORN; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SEQUENCE ANALYSIS;

ACUTE DISEASE; ADOLESCENT; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 9; DNA-BINDING PROTEINS; ETOPOSIDE; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOID; MALE; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0037377078     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10167     Document Type: Article

References (32)

1. Atlas M, Head D, Behm F, Schmidt E, Zeleznik Le NH, Roe BA, Burian D, Domer PH. 1998. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Leukemia 12: 1895-1902.
2. Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH. 1996. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 87:2870-2877.
3. Bernard OA, Berger R. 1995. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferation. Genes Chromosomes Cancer 13:75-85.
4. Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA, Evans G, Young BD. 1994. Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood 84:3776-3780.
5. Broeker P, Super H, Thirman M, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik Le N, Rowley J. 1996. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87:1912-1922.
6. Canaani E, Nowell PC, Croce CM. 1995. Molecular genetics of 11q23 chromosome translocations. Adv Cancer Res 66:213-234.
7. Cimino G, Rapanotti MC, Rivolta A, Lo Coco F, D'Arcangelo E, Rondelli R, Basso G, Barisone E, Rosanda C, Santostasi T, Canaani E, Masera G, Mandelli F, Biondi A. 1995. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia 9:391-395.
8. Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ. 1993. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 90:7884-7888.
9. Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ. 1995. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85:3250-3256.
10. Gellert M. 1992. V(D)J recombination gets a break. Trends Genet 8:408-412.
11. Gillert E, Leis T, Repp R, Reichel M, Hosch A, Breitenlohner I, Angermuller S, Borkhardt A, Harbott J, Lampert F, Griesinger F, Greil J, Fey GH, Marschalek R. 1999. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 18:4663-4671.
12. Gill Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD. 1993. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705-3711.
13. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E. 1992. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71:701-708.
14. Hilden JM, Kersey JH. 1994. The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studies. Leuk Lymphoma 14:189-195.
15. Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH. 1995. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4;11)(q21;q23). Blood 86:3876-3882.
16. Larson RA, Le Beau MM, Vardiman JW, Rowley JD. 1996. Myeloid leukemia after hematotoxins. Environ Health Perspect 104:1303.
17. Lovett B, Strumberg D, Blair I, Pang S, Burden D, Megonigal M, Rappaport E, Rebbeck T, Osheroff N, Pommier Y, Felix C. 2001. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints. Biochemistry 40:1159-1170.
18. Negrini M, Felix CA, Martin C, Lange BJ, Nakamura T, Canaani E, Croce CM. 1993. Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia. Cancer Res 53:4489-4492.
19. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
20. Roth D, Porter T, Wilson J. 1985. Mechanisms of nonhomologous recombination in mammalian cells. Mol Cell Biol 5:2599-2607.
21. Rowley JD. 1993. Rearrangements involving chromosome band 11q23 in acute leukemia. Semin Cancer Biol 4:377.
22. Rowley JD. 1998. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 32:495-519.
23. Sim S, Liu L. 2002. Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J Biol Chem 276:31590-31595.
24. Sorensen PHB, Chen C-S, Smith FO, Arthur DC, Domer PH, Bernstein ID, Korsmeyer SJ, Hammond GD, Kersey JH. 1994. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 93:429-437.
25. Stanulla M, Wang J, Chervinsky DS, Thandla S, Aplan PD. 1997. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 17:4070-4079.
26. Strick R, Strissel P, Borgers S, Smith S, Rowley J. 2000. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97:4790-4795.
27. Strissel P, Strick R, Tomek R, Roe B, Rowley J, Zeleznik Le N. 2000. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 9:1671-1679.
28. Strissel PL, Strick R, Rowley JD, Zeleznik Le NJ. 1998. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92:3793-3803.
29. Strout MP, Marcucci G, Bloomfield CD, Caligiuri MA. 1998. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci USA 95:2390-2395.
30. Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik Le NJ, Diaz MO, Rowley JD. 1997. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer 20: 185-195.
31. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, Le Beau MM, Diaz MO, Rowley JD. 1993. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909-914.
32. Yamamoto K, Seto M, Iida S, Komatsu H, Kamada N, Kojima S, Kodera Y, Nakazawa S, Saito H, Takahashi T, Ueda R. 1994. A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 83:2912-2921.